trending Market Intelligence /marketintelligence/en/news-insights/trending/d6ttfukzod7ijbhxc06fga2 content esgSubNav
In This List

Rockwell Medical appoints CEO

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Rockwell Medical appoints CEO

Rockwell Medical Inc. appointed Stuart Paul as CEO.

The Wixom, Mich.-based biopharmaceutical company had fired its previous CEO and issued restraining orders against him. The company recently reached a settlement agreement with the former CEO and others.

Paul will take charge as CEO from Sept. 4 and will also become a board member. He last served as the corporate officer and vice president of Abbott Laboratories and was responsible for facilitating the acquisition of Alere Inc. by Abbott.

Rockwell focuses on developing therapies for kidney diseases and for patients undergoing dialysis.